This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Allgenesis Biotherapeutics Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Madhu Cherukury: Innovator in Biotherapeutics
Introduction
Madhu Cherukury is a prominent inventor based in Irvine, CA (US). He has made significant contributions to the field of biotherapeutics, particularly in the area of angiogenesis inhibition. With a total of 2 patents, his work is paving the way for innovative treatments in medicine.
Latest Patents
Cherukury's latest patents include a VEGFR fusion protein pharmaceutical composition. This invention relates to a biologic that inhibits angiogenesis, specifically through fusion proteins that target both the integrin activated pathway and another angiogenic factor-activated pathway. Additionally, he has developed fusion proteins for inhibiting angiogenesis, which also focus on the same pathways and include methods for producing and utilizing these compositions.
Career Highlights
Madhu Cherukury is currently associated with Allgenesis Biotherapeutics Inc., where he continues to advance his research and development efforts. His work is crucial in the ongoing fight against diseases that involve abnormal blood vessel growth.
Collaborations
Cherukury collaborates with talented individuals such as Tan Nguyen and Pei-Tzu Wu, who contribute to the innovative environment at Allgenesis Biotherapeutics Inc.
Conclusion
Madhu Cherukury's contributions to biotherapeutics through his patents and collaborations highlight his role as a key innovator in the field. His work continues to inspire advancements in medical treatments aimed at inhibiting angiogenesis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile